# 10K Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/10k-genomics

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.10kgenomics.com
- Total disclosed funding: $16M
- Latest round: Series A (Dec 30, 2021)
- Investors on record: 4

## About

Established in 2018 and based in Beijing, China, 10K Genomics is a biotech company that provides single-cell gene omics analysis. The company's market covers China, and US state. 

The company provides single cell sequencing instruments and reagents. Products and services can be divided single cell immune sequencing, high-throughput single cell transcriptome sequencing, low throughput single cell transcriptome sequencing, and assay for transposase accessible chromatin with high-throughput sequencing (ATAX-seq). The single cell sequencer, Perseus, and supporting high-throughput transcriptome reagents, have entered the testing phase, which has the feature of high throughput, high capture rate, and selecting the number of chips according to the number of samples. Single cell sequencing will become a research and testing tool in scientific research, clinical and industrial scenarios.

The company plans to iterate single-cell sequencing technology and related omics products. Moreover, the company plans to develop the single-cell sequencing equipment.

## Funding rounds

- Series A, Dec 30, 2021, $16M — NLVC, CD Capital, Qiandao Investment Fund Management
- Angel, Mar 22, 2019, $0.7M — Empower Investment

## Investors

- Empower Investment (https://capitalatlas.ai/funds/empower-investment) — Angel
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A
- CD Capital — Series A
- Qiandao Investment Fund Management (https://capitalatlas.ai/funds/qiandao-investment-fund-management) — Series A